FCE 26644

Known as: FCE-26644 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1994-1999
0119941999

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
Suramin has shown promising antitumour activity against several tumour types, both in vitro and in vivo, but the clinical utility… (More)
Is this relevant?
1999
1999
PNU 145156E (formerly FCE 26644) is a noncytotoxic molecule whose antitumor activity is exerted through the formation of a… (More)
  • figure 2
  • figure 1
  • table 1
  • table 2
  • table 3
Is this relevant?
1997
1997
1. The purpose of this study was to investigate the antiproliferative effect and the modulation of the mitogenic insulin-like… (More)
Is this relevant?
1996
1996
A sensitive and selective ion-pair high-performance liquid chromatographic method for the determination of 7,7'-carbonylbis[imino… (More)
Is this relevant?
1995
1995
FCE 26644, or 7,7′-(carbonyl-bis[imino-N-methyl-4, 2 pyrrole carbonyl-imino{N-methyl-4, 2-pyrrole}carbonylimino])-bis-(1, 3… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
Is this relevant?
1994
1994
Tumor-induced neoangiogenesis is an essential event for solid tumor growth. Therefore, a compound able to block angiogenesis… (More)
Is this relevant?